Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...

Knee embolism is an outpatient procedure that blocks or reduces blood flow to the knee, usually to treat conditions that ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

MANY clinical and experimental studies have been performed to study the etiology, diagnosis and treatment of traumatic fat embolism. Recently, a less well understood counterpart, termed ...

BAY-3018250 is under clinical development by Bayer and currently in Phase II for Pulmonary Embolism. According to GlobalData, Phase II drugs for Pulmonary Embolism have an 80% phase transition success ...